MRNS - Marinus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.10 revenue of $6.08M beats by $0.34M
2023-08-10 07:14:38 ET
- Marinus Pharmaceuticals press release ( NASDAQ: MRNS ): Q2 GAAP EPS of -$0.61 beats by $0.10 .
- Revenue of $6.08M (+237.8% Y/Y) beats by $0.34M .
- Cash runway expected into second half of 2024 with cash, cash equivalents and short-term investments of $175.3 million as of June 30, 2023.
For further details see:
Marinus Pharmaceuticals GAAP EPS of -$0.61 beats by $0.10, revenue of $6.08M beats by $0.34M